Greenbrook TMS Inc. announced that it has appointed Ms. Surindra Mann to the Company's board of directors (the "Board") as an independent director, filling the vacancy created by the resignation of Dr. Adrienne Graves, Ph.D., effective immediately. Surindra Mann is a dynamic finance executive with over 20 years of experience at public companies driving transformational change at the intersection of business and strategy. Ms. Mann possesses extensive finance and accounting expertise in high growth environments, primarily in the medical device industry.

Ms. Mann is currently the vice-president, global finance, at STAAR Surgical, a position she has held since 2017. Prior to her role at STAAR Surgical, Ms. Mann held multiple positions at Abbott Labs leading all aspects of finance during her more than 15-year tenure. Ms. Mann currently serves on the board of directors of Beyond Blindness where she also served as a member of its finance, governance and audit committees.

Ms. Mann received a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant (CMA, Ontario, Canada). Dr. Adrienne Graves, Ph.D., who has resigned as a member of the Board, served as an independent director since the Company's initial public offering in 2018, was chair of the Governance and Nominating Committee, and was a member of the Compensation Committee and Audit Committee during her tenure. In connection with Dr. Graves' resignation, Ms. Mann has been appointed to the Audit Committee.

Mr. Frank Tworecke, a current director and member of the Governance and Nominating Committee, will now serve as chair of the Governance and Nominating Committee.